Clin2
NCT07227909Possibly a fitNot yet recruiting

Psilocybin to prevent nerve damage from chemo

PsilocybinNeuropathy

Treatments studied

Part of Brain & nervous system, Cancer, Mental health, Pain clinical trials.

This study tests whether psilocybin (a psychedelic compound) can prevent nerve damage caused by chemotherapy. If you are receiving certain types of chemo for breast, colorectal, or head and neck cancer, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
83 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older
  • You must have breast, colorectal, or head and neck cancer
  • You must be scheduled to receive platinum-based chemo or taxanes (like paclitaxel or docetaxel)
  • You must not have significant existing nerve damage (neuropathy) from prior treatment
  • You must be able to travel to MD Anderson Cancer Center for all visits
  • You must agree to avoid alcohol, nicotine, and other psychoactive drugs around the psilocybin sessions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06389721Recruiting
Preventing nerve damage from breast cancer chemotherapy

This study looks at how certain chemotherapy drugs affect the brain and cause nerve damage (peripheral neuropathy) in people with breast cancer. The goal is to find ways to prevent or reduce these side effects so that treatment can be more comfortable and effective.

Houston, Texas
NCT06731894Recruiting· Phase 2
Cannabis for nerve pain after chemotherapy in breast and colon cancer survivors

This trial tests whether a cannabis-based product can reduce nerve damage (neuropathy) caused by chemotherapy in people who have finished treatment for breast or colon cancer. It focuses on survivors who still have pain, numbness, or tingling in their hands or feet.

Duarte, California
NCT06731335Recruiting· Phase 2
Psilocybin for chronic nerve pain that hasn't improved with other treatments

This study tests whether psilocybin (a compound found in certain mushrooms) can help reduce chronic nerve pain that has not responded well to standard medications. You will receive study treatment plus psychotherapy to see if it improves your pain.

Toronto, Ontario
NCT06596122Not yet recruiting· Phase 2
Vitamin D to prevent nerve damage from chemotherapy in breast cancer

This trial tests whether taking vitamin D supplements can prevent nerve damage (a common side effect) caused by paclitaxel chemotherapy in women with early-stage breast cancer. If you have low vitamin D levels, you may be able to join.

Cairo
NCT07423390Recruiting· Phase 3
Vitamin B12 to prevent nerve damage from chemo

This trial tests if taking mecobalamin (a form of vitamin B12) can prevent or reduce nerve pain and numbness caused by taxane chemotherapy. It may help people getting chemo for several types of cancer.

Xining, Qinghai
NCT06522685Not yet recruiting
Brain stimulation for chemotherapy nerve pain

This study tests a non-invasive brain stimulation treatment to see if it can reduce nerve pain caused by chemotherapy. It also looks at how the treatment affects the brain and immune system.

Baltimore, Maryland

Hear when a new Psilocybin trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.